Reuters: Mergers News: Watson profit tops Wall Street estimate

Reuters: Mergers News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Watson profit tops Wall Street estimate Apr 30th 2012, 11:21 April 30 | Mon Apr 30, 2012 7:21am EDT April 30 (Reuters) - Watson Pharmaceuticals Inc posted higher-than-expected quarterly profit on Monday, as generic versions of the Lipitor cholesterol fighter and Lovenox blood thinner helped revenue soar by 74 percent. First-quarter net income rose to $54.8 million, or 43 cents per share, from $45.3 million, or 36 cents per share, a year earlier. Excluding special items, earnings of $1.64 topped the average estimate of analysts by 4 cents per share, according to Thomson Reuters I/B/E/S. Last week, Watson agreed to pay at least $5.6 billion for privately held Actavis to cement its status as one of the world's biggest suppliers of generic drugs and expand further internationally.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions